4.6 Review

Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution

Related references

Note: Only part of the references are listed.
Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Review Chemistry, Medicinal

Expedition of sulfur-containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update

Kritika Laxmikeshav et al.

Summary: This review provides a comprehensive report on the design strategies of sulfur-bearing cytotoxic agents and their potential in anticancer therapy. The article discusses various sulfur-containing heterocyclic scaffolds and their cytotoxic effects through multiple mechanisms. The assessment of antiproliferative activities allows for a proficient evaluation of the structure-activity relationships of the synthesized molecules.

MEDICINAL RESEARCH REVIEWS (2022)

Article Biochemistry & Molecular Biology

beta-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies

Hari Krishna Namballa et al.

Summary: In this study, a series of beta-carboline-cinnamide conjugates were synthesized and one compound, 7h, displayed superior HDAC inhibitory activity and antiproliferative activity against cancer cell lines. Compound 7h showed promising potential for further investigation as a novel anti-cancer drug targeting HDACs.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies

Sravani Sana et al.

Summary: The study introduces a novel class of compounds with moderate to interesting cytotoxicity against various cancer cell lines, with compound 18i showing the highest potency and specificity towards A549 (lung cancer) cells. Flow cytometry analysis revealed that 18i induced G2/M phase cell cycle arrest, indicating potential anticancer activity. The most active compound, 18i, demonstrated enhanced microtubule disruption and significant antitumor effects through multiple mechanisms, including apoptosis induction, ROS generation, and inhibition of cellular migration.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Medicinal

Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances

Prajwal Dhokne et al.

Summary: Small-molecule kinase inhibitors are being explored as promising anticancer therapeutics due to the deregulation of kinases in cancerous tissues. Oxindole motifs have shown significant inhibitory activity against multiple kinases, making them privileged scaffolds for development. Recent advances in oxindole-based kinase inhibitors, including their structural frameworks, design strategies, and mechanism of action have been summarized in this review.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Chemistry, Medicinal

Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition

Darshana Bora et al.

Summary: Spirocompounds, an important class of organic frameworks, have shown promising anticancer potential, inspiring medicinal chemists to explore new derivatives with improved pharmacological properties. By investigating the anticancer activity and structure-activity relationships of various spirocompounds, this review may guide the design of novel spiromolecules with enhanced safety and efficacy in the future.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities

Yichang Ren et al.

Summary: Novel indazole and benzimidazole analogues, such as compound 12b, demonstrated potent antiproliferative activities against cancer cells, with IC50 values comparable to colchicine. Compound 12b also showed in vivo antitumor efficacy in a melanoma tumor model, suggesting its potential as a promising lead compound for further investigation as a potential anticancer agent.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Unravelling KDM4 histone demethylase inhibitors for cancer therapy

Stephin Baby et al.

Summary: Epigenetic enzyme-targeted therapy is a promising development in drug discovery, with histone deacetylases and DNA methyltransferases being investigated as druggable targets. Recently, histone methyltransferases and lysine demethylase inhibitors have become the focus of clinical trials as potential epi-drugs. KDM4 enzymes, part of the 2-OG-dependent oxygenases group, have attracted attention as novel targets in cancer therapy, with efforts being made to develop selective small molecule inhibitors.

DRUG DISCOVERY TODAY (2021)

Article Chemistry, Multidisciplinary

Targeting tubulin polymerization and DNA binding of 4-thiazolidinone-umbelliferone hybrids: synthesis and cytotoxicity evaluation

Dilep Kumar Sigalapalli et al.

Summary: A series of novel cytotoxic agents inspired by combretastatin A-4 were reported, with compound 7q showing the highest potency against A549 cells through induction of apoptosis and inhibition of tubulin polymerization. Molecular modeling studies revealed 7q's prominent binding affinity towards the alpha/beta-tubulin receptor with remarkable protein-ligand interactions.

NEW JOURNAL OF CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

β-Carboline-based molecular hybrids as anticancer agents: a brief sketch

Jay Prakash Soni et al.

Summary: This review focuses on the development of beta-carboline-based chemotherapeutic agents in the past five years, highlighting molecular hybrids of beta-carbolines with various pharmacophores, synthetic strategies, and in vitro anticancer evaluation. The mechanisms of action, in silico studies, and structural influence on potency and selectivity among different cancer cell lines are critically discussed, providing updates on potential molecules for future development of novel cytotoxic agents.

RSC MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Structural insights into the design of indole derivatives as tubulin polymerization inhibitors

Yuanyuan Li et al.

FEBS LETTERS (2020)

Article Biology

Mechanics and kinetics of dynamic instability

Thomas C. T. Michaels et al.

ELIFE (2020)

Review Cell Biology

The Tubulin Code in Mitosis and Cancer

Danilo Lopes et al.

CELLS (2020)

Review Chemistry, Medicinal

Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review

Eavan C. McLoughlin et al.

PHARMACEUTICALS (2020)

Review Chemistry, Medicinal

Combretastatin-based compounds with therapeutic characteristics: a patent review

Lalit Mohan Nainwal et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2019)

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents

Mirza Feroz Baig et al.

BIOORGANIC CHEMISTRY (2018)

Article Chemistry, Medicinal

Synthesis and anticancer activity of novel water soluble benzimidazole carbamates

Jae Eun Cheong et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Medicinal

Therapeutic evolution of benzimidazole derivatives in the last quinquennial period

Wasim Akhtar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation, and apoptosis inducing studies

Niggula Praveen Kumar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Synthesis of arylpyrazole linked benzimidazole conjugates as potential microtubule disruptors

Ahmed Kamal et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Synthesis of 2-aryl-1,2,4-oxadiazolo-benzimidazoles: Tubulin polymerization inhibitors and apoptosis inducing agents

Ahmed Kamal et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity

Sangram S. Kale et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Biochemistry & Molecular Biology

Synthesis and biological evaluation of benzimidazole-oxindole conjugates as microtubule-targeting agents

Ahmed Kamal et al.

BIOORGANIC CHEMISTRY (2015)

Article Chemistry, Medicinal

A facile synthesis and microtubule-destabilizing properties of 4-(1H-benzo[d]imidazol-2-yl)-furazan-3-amines

Andrei I. Stepanov et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

New benzimidazole-2-urea derivates as tubulin inhibitors

Wenna Wang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

Review Chemistry, Medicinal

Recent developments in tubulin polymerization inhibitors: An overview

Ramandeep Kaur et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs

Andrea E. Prota et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Chemistry, Medicinal

Design, synthesis and biological studies of novel tubulin inhibitors

Yanjun Sun et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Synthesis of terphenyl benzimidazoles as tubulin polymerization inhibitors

Ahmed Kamal et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Review Chemistry, Medicinal

Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents

Shivaputra A. Patil et al.

FUTURE MEDICINAL CHEMISTRY (2012)

Review Oncology

The cell cycle and cancer

Gareth H. Williams et al.

JOURNAL OF PATHOLOGY (2012)

Review Biotechnology & Applied Microbiology

Microtubule-binding agents: a dynamic field of cancer therapeutics

Charles Dumontet et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Oncology

How do microtubule-targeted drugs work? An overview

Mary Ann Jordan et al.

CURRENT CANCER DRUG TARGETS (2007)

Article Chemistry, Medicinal

Indole, a core nucleus for potent inhibitors of tubulin polymerization

Andrea Brancale et al.

MEDICINAL RESEARCH REVIEWS (2007)

Review Cell Biology

The tubulin code

Kristen J. Verhey et al.

CELL CYCLE (2007)

Review Chemistry, Multidisciplinary

Natural terphenyls: Developments since 1877

Ji-Kai Liu

CHEMICAL REVIEWS (2006)

Review Oncology

Microtubules as a target for anticancer drugs

MA Jordan et al.

NATURE REVIEWS CANCER (2004)